A two-plasmid system for stable, selective-pressure-independent expression of multiple extracellular proteins in mycobacteria

Microbiology

Volumn 150, Issue 7, 2004, Pages 2143-2151

  Harth, Günter ^a   Masleša Galić, Saša ^a   Horwitz, Marcus A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIMYCOBACTERIAL AGENT; APRAMYCIN; BACTERIAL DNA; BACTERIAL PROTEIN; BCG VACCINE; CHLORAMPHENICOL; FBPB PROTEIN; HYGROMYCIN; KANAMYCIN; MYCOBACTERIUM VACCINE; NEW DRUG; PLASMID VECTOR; PYRAZINAMIDE; RECOMBINANT PROTEIN; STREPTOMYCIN; TETRACYCLINE; THIOPHENE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DRUG POTENCY; DRUG RESEARCH; ESCHERICHIA COLI; GENE EXPRESSION; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN STABILITY; TUBERCULOSIS;

CORYNEBACTERINEAE; ESCHERICHIA COLI; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; VECTORS;

EID: 4344564957     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.27113-0     Document Type: Article

References (28)

1. Anderson, D. H., Harth, G., Horwitz, M. A. & Eisenberg, D. (2001). An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30 kDa major secretory protein (antigen 85B), a mycolyl transferase. J Mol Biol 307, 671-681.
2. Bachrach, G., Colston, M. J., Bercovier, H., Bar-Nir, D., Anderson, C. & Papavinasasundaram, K. G. (2000). A new single-copy mycobacterial plasmid, pMF1, from Mycobacterium fortuitum which is compatible with the pAL5000 replicon. Microbiology 146, 297-303.
3. Belisle, J. T., Vissa, V. D., Sievert, T., Takayama, K., Brennan, P. J. & Besra, G. S. (1997). Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 276, 1420-1422.
4. Cheng, L. W., Anderson, D. M. & Schneewind, O. (1997). Two independent type III secretion mechanisms for YopE in Yersinia enterocolitica. Mol Microbiol 24, 757-765.
5. Cohn, D. L., Bustreo, F. & Raviglione, M. C. (1997). Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union against Tuberculosis and Lung Disease. Clin Infect Dis 24 (Suppl 1), S121-S130.
6. Cole, S. T., Brosch, R., Parkhill, J. & 39 other authors (1998). Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544.
7. Garbe, T. R., Barathi, J., Barnini, S., Zhang, Y., Abou-Zeid, C., Tang, D., Mukherjee, R. & Young, D. B. (1994). Transformation of mycobacterial species using hygromycin resistance as selectable marker. Microbiology 140, 133-138.
8. Gavigan, J. A., Ainsa, J. A., Perez, E., Otal, I. & Martin, C. (1997). Isolation by genetic labeling of a new mycobacterial plasmid, pJAZ38, from Mycobacterium fortuitum. J Bacteriol 179, 4115-4122.
9. Harth, G., Clemens, D. L. & Horwitz, M. A. (1994). Glutamine synthetase of Mycobacterium tuberculosis: extracellular release and characterization of its enzymatic activity. Proc Natl Acad Sci U S A 91, 9342-9346.
10. Harth, G., Lee, B.-Y., Wang, J., Clemens, D. L. & Horwitz, M. A. (1996). Novel insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis. Infect Immun 64, 3038-3047.
11. Harth, G., Lee, B.-Y. & Horwitz, M. A. (1997). High-level heterologous expression and secretion in rapidly growing nonpathogenic mycobacteria of four major Mycobacterium tuberculosis extracellular proteins considered to be leading vaccine candidates and drug targets. Infect Immun 65, 2321-2328.
12. Harth, G., Horwitz, M. A., Tabatadze, D. & Zamecnik, P. C. (2002). Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: proof of principle by using antisense technology. Proc Natl Acad Sci U S A 99, 15614-15619.
13. Herrmann, J. L., O'Gaora, P., Gallagher, A., Thole, J. E. R. & Young, D. B. (1996). Bacterial glycoproteins: a link between glycosylation and proteolytic cleavage of a 19 kDa antigen from Mycobacterium tuberculosis. EMBO J 15, 3547-3554.
14. Horwitz, M. A. & Harth, G. (2003). A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis. Infect Immun 71, 1672-1679.
15. Horwitz, M. A., Lee, B.-W. E., Dillon, B. J. & Harth, G. (1995). Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 92, 1530-1534.
16. Horwitz, M. A., Harth, G., Dillon, B. J. & Maslesa-Galic, S. (2000). Recombinant BCG vaccines expressing the Mycobacterium tuberculosis 30 kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci U S A 97, 13853-13858.
17. Howard, N. S., Gomez, J. E., Ko, C. & Bishai, W. R. (1995). Color selection with a hygromycin-resistance-based Escherichia coli-mycobacterial shuttle vector. Gene 166, 181-182.
18. Jacobs, W. R., Jr, Kalpana, G. V., Cirillo, J. D., Pascopella, L., Snapper, S. B., Udani, R. A., Jones, W., Barletta, R. G. & Bloom, B. R. (1991). Genetic systems for mycobacteria. Methods Enzymol 204, 537-555.
19. Jungblut, P. R., Schaible, U. E., Mollenkopf, H. J. & 7 other authors (1999). Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens. Mol Microbiol 33, 1103-1117.
20. Kaps, I., Ehrt, S., Seeber, S., Schnappinger, D., Martin, C., Riley, L. W. & Niederweis, M. (2001). Energy transfer between fluorescent proteins using a co-expression system in Mycobacterium smegmatis. Gene 278, 115-124.
21. Lee, B.-Y. & Horwitz, M. A. (1995). Identification of macrophage and stress-induced proteins of Mycobacterium tuberculosis. J Clin Invest 96, 245-249.
22. Pablos-Mendez, A., Raviglione, M. C., Laszlo, A. & 8 other authors (1998). Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 338, 1641-1649.
23. Paget, E. & Davies, J. (1996). Apramycin resistance as a selective marker for gene transfer in mycobacteria. J Bacteriol 178, 6357-6360.
24. Pashley, C. A., Parish, T., McAdam, R. A., Duncan, K. & Stoker, N. G. (2003). Gene replacement in mycobacteria by using incompatible plasmids. Appl Environ Microbiol 69, 517-523.
25. Picardeau, M. & Vincent, V. (1997). Characterization of large linear plasmids in mycobacteria. J Bacteriol 179, 2753-2756.
26. Pushnova, E. A., Geier, M. & Zhu, Y. S. (2000). An easy and accurate agarose gel assay for quantitation of bacterial plasmid copy numbers. Anal Biochem 284, 70-76.
27. Rose, J. D., Maddry, J. A., Comber, R. N., Suling, W. J., Wilson, L. N. & Reynolds, R. C. (2002). Synthesis and biological evaluation of trehalose analogs as potential inhibitors of mycobacterial cell wall biosynthesis. Carbohydr Res 337, 105-120.
28. Tullius, M. V., Harth, G. & Horwitz, M. A. (2003). Glutamine synthetase GlnA1 is essential for growth of Mycobacterium tuberculosis in human THP-1 macrophages and guinea pigs. Infect Immun 71, 3927-3936.